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SUMMARY 
An effective fermentation organism is a wasteful creature 
that overproduces and excretes its metabolic intermediates and 
end products. Cultures obtained from screening programs usu-
ally possess subnormal regulatory controls. Development pro-
grams to increase product formation modify the residual control 
mechanisms so that the culture's "inefficiency" is increased. 
For production of primary metabolites, feedback inhibi-
tion and repression must be bypassed. This is usually accom-
plished by limiting the intracellular concentration of feedback 
inhibitors and repressors. Auxotrophic mutants and analogue-
resistant mutants are most often used for this purpose. Devel-
opment of fermentations for secondary metabolites, such as 
antibiotics, is less rational because of our ignorance of the 
biosynthetic pathways and regulatory controls involved. How-
ever, evidence is accumulating that such fermentations are sub-
ject to (a) feedback regulation by the idiolite itself, (b) 
feedback regulation by primary metabolites that share a branched 
pathway with the secondary metabolite, {c) feedback regulation 
by inorganic phosphate, (d) catabolite regulation by rapidly 
utilized carbon sources, (e) induction by primary metabolites, 
and (f) ATP regulation. Secondary metabolites are not usually 
formed during growth because the enzymes of secondary metabol-
ism are repressed during the trophophase. We have no clear 
idea about the type of repression control, but it probably in-
volves growth rate as well as the factors mentioned above. 
Since the controls discussed above are genetically deter-
mined, mutations to increase productivity have been useful to 
the fermentation industry for over 30 years. Although such 
strain improvement programs usually involve random screening 
of survivors of mutagenesis, some recent progress has been made 
in the application of more rational screening procedures. 
Mutants are also used to change the spectrum of metabolites, to 
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produce new antibiotics, and to elucidate the pathways of sec-
ondary metabolism. 
Extensive research is now taking place on the genetic map-
ping of antibiotic-producing microorganisms, especially actino-
mycetes. The model for this work is the genetic map of Strepto-
myces coelicolor, and the maps of more recently examined actino-
mycetes, including Nocardia, appear to be similar. At least 
four of the genes of methylenomycin A production in S. coeli-
color are plasmid-bound. 
INTRODUCTION 
A growing microorganism breaks down high molecular weight 
carbon and energy sources, brings the smaller derivatives into 
the cell, degrades them to smaller molecules, converts these to 
amino acids, nucleotides, vitamins, carbohydrates, and fatty 
acids, and finally builds these basic materials into proteins, 
coenzymes, nucleic acids, mucopeptides, polysaccharides, and 
lipids. Hundreds of enzymes must be made and must act in an 
integrated manner to avoid total chaos. To do this, regulatory 
mechanisms have evolved that enable a species to compete effi-
ciently with other forms of life and- to survive in nature. 
Thus, the ideal cell does not overproduce metabolites, regard-
less of its environment. Some of the important control mechan-
isms are substrate induction, feedback regulation, catabolite 
regulation, and energy charge regulation. 
Let us now shift our attention from the viewpoint of the 
microorganism to that of the fermentation microbiologist. What 
we desire is a wasteful strain, which will overproduce and ex-
crete a particular compound that can then be isolated (DEMAIN, 
1972). Usually, organisms from culture collections or from 
nature are first screened for their ability to overproduce the 
desired product. Without necessarily realizing it, the micro-
biologist is searching for the organism with the weakest regula-
tory mechanisms. Once the desired strain is found, a develop-
ment program is begun to improve yields by modification of cul-
ture conditions and by mutation. The microbiologist is actually 
modifying the regulatory controls remaining in the original cul-
ture so that its inefficiency can be further increased. Until 
very recently, these manipulations were done in total ignorance 
of the basic factors involved. Due to the increase in our know-
ledge of microbial biochemistry and genetics, we now have some 
idea of these factors, and new fermentation processes for pri-
mary products, such as amino acids, vitamins, and purine nucleo-
tides, are being developed on a more rational basis. On the 
other hand, the development of fermentations for secondary me-
tabolites (those with no function in growth) still relies mainly 
on the empirical approach because of our ignorance of the path-
ways and the regulatory circuits involved in secondary metab-
olism. 
Only within the last few years has evidence begun to ac-
cumulate to support the thesis that the organisms selected by 
our screening procedures are, in fact, subnormally regulated. 
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For example, Corynebacterium glutamicum , a species used for the 
commercial production of L-lysine, has been found to possess an 
initial enzyme of the lysine branch (dihydrodipicolinate s yn-
thetase) that is resistant to feedback inhibition by lysine 
(NAKAYAMA et al., 1966). In Claviceps paspali , the production 
of alkaloids involves a precursor, tryptophan. In this organism, 
the first enzyme of the tryptophan biosynthetic branch (anthra-
nilate synthetase) is resistant to feedback inhibition by tryp-
tophan (LINGENS et al., 1967), thus allowing for tryptophan 
overproduction. Chloramphenicol production by Streptomyces sp. 
occurs by a shunt pathway from shikimic acid, a normal inter-
mediate in aromatic amino acid biosynthesis. In the producing 
organism, the first enzyme of aromatic biosynthesis [3-deoxy-
D-a r abino-heptulosonate 7-phosphate (DAHP ) synthetase] resists 
feedback inhibition and repression by phenylalanine, tryptophan, 
and tyrosine (LOWE and WESTLAKE, 1971). 
OVERPRODUCTION OF PRIMARY METABOLITES 
In biosynthetic pathways leading to primary metabolites, 
the main regulatory control mechanism is feedback, which in-
volves inhibition of an early biosynthetic enzyme and/ or re-
pression of one or more of the biosynthetic enzymes by the 
final product or its derivative. Most processes designed to 
produce primary metabolites work by limiting the intracellular 
concentration of feedback inhibitors or repressors. Usually , 
one employ s an auxotrophic mutant. Since such an organism re-
quires the end product for growth, one can limit the intracel-
lular concentration of this inhibitory or repressive end pro-
duct by feeding it to the culture at growth-limiting levels; 
feedback regulation is then by passed, and high levels of the 
desired intermediate accumulate. Some examples are given in 
Table 1. 
TABLE 1 
Overproduction of Primary Metabolites 
A . By par t ial s t arvation of auxotrophic mutants 
Product 
L-Glutamic acid 
L-Lysine 
L-Threonine 
Auxotrophic requirement 
Glycerol 
Homoserine 
Ly sine, methionine, 
isoleucine 
B. By selecting antimetabolite - resistant mutants 
Product 
L-Threonine 
L-Methionine 
L-Tryptophan 
Antimetabolite resistance 
a -Amino- B-hydroxyvaleric 
acid 
Ethionine 
5-Fluorotryptophan 
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A second way to eliminate feedback regulation and accumu-
late primary metabolites is to alter the structure of the enzyme 
subject to inhibition or to modify the regulatory genes so that 
the system is no longer repressible. This modification is done 
by selecting mutants that resist the toxic effects of an ana-
logue of the desired product. Many of the resistant mutants 
overproduce and excrete the natural end product (Table 1). Cer-
tain feedback-resistant overproducing mutants possess desensi-
tized enzymes, whereas others have derepressed enzyme-forming 
systems. Strains with both types of mutation usually show 
synergistic excretion of the natural metabolite. 
FEEDBACK REGULATION OF SECONDARY METABOLISM 
The major obstacle in applying the above clear-cut prin-
ciples to the rational development of secondary metabolite fer-
mentations has been our ignorance; we knew little of the path-
way intermediates, less about the enzymes, and almost nothing 
about the feedback regulation of se~ondary metabolism. How-
ever, the situation is changing rapidly as we learn more and 
more about secondary biosynthesis and its control (DREW and 
DEMAIN, 1975a). 
Considerable -evia.ence is - accumulating - that - secondary me-
tabolites (or idiolites) exert feedback regulation on their 
own formation. For example, antibiotics such as chlorampheni-
col (JONES and WESTLAKE, 1974), ristomycin (EGOROV et al., 
1971), virginiamycin (YANAGIMOTO and TERUI, 1971a), aurodox 
(LIU et al., 1975b), cycloheximide (KOMINEK, 1975), penicillin 
(GORDEE and DAY, 1972), and mycophenolic acid (MUTH and NASH, 
1975)- limit their own synthesis. With the exceptions of chlor-
amphenicol and mycophenolic acid, the feedback mechanism(s) is 
unknown. Chloramphenicol feedback acts by repressing arylamine 
synthetase (JONES and WESTLAKE, 1974). This newly discovered 
enzyme is the first enzyme of the chloramphenicol branch of 
the aromatic amino acid biosynthetic pathway, which converts 
chorismic acid to an identified aromatic amine. In the pro-
ducing culture, this key enzyme is produced just before chlor-
amphenicol formation and then rapidly disappears. Maximum re-
pression occurs at 100 mg/liter, a concentration of the anti-
biotic that does not affect growth or markedly repress choris-
mate mutase, prephenate dehydratase, or anthranilate synthet-
ase. Mycophenolic acid inhibits its own formation by inhibit-
ing the final enzyme, an O-methyltransferase, in Peniaillium 
stoloniferum (MUTH and NASH, 1975). 
Feedback regulation is also observed in nonantibiotic 
idiolites. In Claviaeps strain SD58, an alkaloid end product, 
elymoclavine, inhibits DAHP synthetase (the first enzyme of 
aromatic amino acid synthesis, which produces the precursor 
tryptophan) _(SCHMAUDER and GROGER, 1973). In addition, the 
first enzyme unique to alkaloid synthesis, dimethylallyl trans-
feras~-'~ inhi_!:>it~ by_ agroclavine and elymoclavine (REINSTEIN 
et al., 1971). 
A second type of feedback regulation is involved in the 
case of branched pathways leading to primary and secondary me-
REGULATION OF FERMENTATION 45 
tabolites. In such cases, negative feedback regulation of an 
early common enzyme by the primary end product might be ex-
pected to diminish production of the idiolite. The original 
finding of the depression of penicillin formation by L-lysine 
(DEMAIN, 1957) was puzzling until it was realized that a-amino-
adipate is an intermediate in the biosynthesis of both lysine 
and penicillins. L-lysine also decreases production of the re-
lated antibiotic cephalosporin C (D'AMATO and PISANO, 1975). 
Lysine diminution of penicillin formation is caused by a 
feedback effect on its own biosynthesis. Although penicillin 
production media do not contain the high levels of free lysine 
required to inhibit penicillin production, the internal concen-
tration of lysine is the important factor in the practical 
sense. In a series of regulatory mutants that overproduce 
lysine, an inverse correlation was found between lysine produc-
tion and penicillin formation (MASUREKAR and DEMAIN, 1974). 
To determine whether lysine reduces penicillin production 
by feedback repression or inhibition, MASUREKAR and DEMAIN 
(1972) studied the effect of lysine on [ 14c)-valine incorpora-
tion into penicillin in short-time experiments. Because the 
presence of lysine during growth did 'lot inhibit subsequent 
valine incorporation by washed mycelial suspensions, repression 
could not have been the inhibitory mechanism. However, marked 
inhibition was observed when lysine was added to the incorpora-
tion mixture. These results indicated that the depressive 
effect of lysine was caused by inhibition of an enzyme involved 
in penicillin biosynthesis. Later studies (DEMAIN and 
MASUREKAR, 1974) showed that the first enzyme of lysine bio-
synthesis, homocitrate synthase, is susceptible to lysine inhi-
bition in cells of P. ahrysogenum. The specific activity of 
this enzyme is high during the trophophase (growth phase) but 
drops at the onset of the idiophase (production stage); the 
residual activity is markedly inhibited by lysine. The result-
ing decrease in the intracellular concentration of L-a-amino-
adipate apparently is the cause of the reduction in penicillin 
formation. 
Similarly, a mixture of the three aromatic amino acids re-
portedly depresses production of candicidin in Streptom y aes 
griseus (LIU et al., 1972). [The active amino acid in the mix-
ture is L-tryptophan (MARTIN and DEMAIN, unpublished results ) .] 
The apparent reason for this depression is that the p-aminoben-
zoic acid moiety of candicidin is made via a branch of the aro-
matic amino acid biosynthetic pathway. 
A third type of feedback regulation involves inorganic 
phosphate. Many fermentations must be conducted in the pre-
sence of levels of inorganic phosphate that are suboptimal for 
growth. In some cases, the diminution in product formation 
caused by phosphate probably involves the well-known feedback 
regulation of phosphatases by inorganic phosphate. Phosphat-
ases must participate in biosynthesis because biosynthetic 
intermediates of many secondary pathways are phosphorylated, 
although the ultimate products are not. For example, strepto-
mycin biosynthesis, which is markedly inhibited by phosphate 
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(DEMAIN and INAMINE, 1970), includes at least three phosphate-
cleaving steps in the formation of the streptidine moiety alone 
(WALKER, 1971). The final enzymatic step in streptomycin pro-
duction appears to be the cleavage of phosphate from strepto-
mycin phosphate. The enzyme catalyzing this reaction is- inhib-
ited by inorganic phosphate (WALKER and WALKER, 1971). Thus 
when a streptomycin fermentation is conducted in a complex 
medium containing a 10 mM phosphate supplement, streptomycin 
production decreases, while the biologically inactive strepto-
mycin phosphate accumulates extracellularly (MILLER and WALKER, 
1970). 
CARBON CATABOLITE REGULATION OF 
SECONDARY METABOLISM 
The inhibition or repression of enzymes by catabolism of a 
rapidly used carbon source, usually glucose, affects secondary 
metabolism. After years of empirical development, most fermen-
tations are now conducted with sources of carbon and energy 
other than glucose. If glucose is used, it is usually fed at 
a slow, continuous rate so that catabolites do not accumulate. 
Glucose markedly decreases alkaloid production by C. pas-
pa li~ sn~ in ~his~ase, poiyols and organi c acids are the pre-
ferred carbon and energy sources. Glucose also suppresses the 
production of actinomycin, penicillin, cephalosporin, violacein, 
indolmycin, prodigiosin, siomycin, mitomycin, bacitracin, neo-
mycin, and coumermycin. When the enniatin fermentation is 
carried out with glucose (which is rapidly utilized), production 
occurs only after growth. If the slowly metabolized lactose is 
used, antibiotic production accompanies growth (ANDHYA and 
RUSSELL, 1975) . Although these effects may be indirectly caused 
by acid production or oxygen depletion, some enzymes of second-
ary biosynthesis are known to be repressed by glucose. One is 
phenoxazinone synthetase (GALLO and KATZ, 1972), an enzyme of 
actinomycin biosynthesis. Galactose is not repressive and is 
preferred as a carbon source for actinomycin formation in a 
chemically defined medium. O-Demethylpuromycin methylase, the 
last enzyme of puromycin biosynthesis, is also repressed by glu-
cose (SANKARAN and POGELL, 1973). In Streptomyces niveus, the 
producer of novobiocin, citrate causes catabolite repression and 
glucose does not (KOMINEK, 1972). In a medium containing ci-
trate and glucose, citrate is used first. Only after citrate 
exhaustion and a diauxic growth lag is glucose used and novo-
biocin formed. 
INDUCTION OF SECONDARY PATHWAYS 
In certain fermentations for secondary metabolites, the re-
sponse to stimulatory additives resembles the phenomenon of en-
zyme-----induction-. - one example involves tryptophan, a stimulatory 
precursor of ergoline alkaloids in Claviceps, Although the 
stimulatory action of tryptophan was once thought to result 
solely from its precursor activity, the following observations 
indicate that it also acts as an inducer of one or more idio-
phase enzymes: (a) tryptophan analogues, such as thiotrypto-
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phan, are not incorporated into alkaloids but still stimulate 
alkaloid production (KRUPINSKI et al., 1976); (b) stimulation 
of alkaloid biosynthesis requires tryptophan addition during the 
trophophase; a later addition has little or no effect (VINING, 
1970); (c) added tryptophan is removed from the medium during 
growth and reaches two- to threefold the normal intracellular 
concentration just before alkaloid production (ROBBERS et al., 
1972). Very recently, KRUPINSKI et al. (1976) showed that the 
addition of tryptophan or thiotryptophan induces the first en-
zyme of alkaloid biosynthesis, dimethylallyl tryptophan syn-
thetase. 
A similar induction-like effect is seen in the stimulation 
by methionine of cephalosporir. C biosynthesis in Ce p halosporium 
ac r emon i um (DEMAIN, 1974a; DREW and DEMAIN, 1975b). The amino 
acid is not required for growth, although it can be used as a 
sole source of nitrogen or sulfur. The mechanism of methionine 
stimulation has been a controversial matter. It is clear that 
methionine sulfur is an efficient precursor of the sulfur atom 
of cephalosporin C; [ 3 5s]-methionine is incorporated into the 
antibiotic in an undiluted state, presumably by the reverse 
transsulfuration pathway (Fig. 1). Despite this evidence of 
methionine sulfur incorporation into antibiotic, it is certain 
that this is not the mechanism responsible for the stimulation 
produced by methionine. 
TRANSSULFURATION 
' 
' 
CEPHALOSPORIN C 
~ 
/ 
/ 
' / / 
"'CYSTE IN E 
I t 
CYSTATHIONINE 
l i REVERSE TRANSSULFURATION 
HOMOCYSTE I NE 
t 
S-ADENOSYLHOMOCYSTE I NE 
t 
S-ADENOSYLMETH ION I NE 
i 
METHIONINE 
Figure 1. Fungal pathway of sulfur metabolism. 
One reason for suspecting a role for methionine other than 
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that of a sulfur precursor was the finding that the amino acid 
exerts its major effect on cephalosporin C synthesis when added 
during growth, i.e., before antibiotic synthesis commences. 
This phenomenon suggested some sort of a regulatory action. 
Another reason was the inability of other sulfur compounds to 
optimize cephalosporin C biosynthesis. Of particular importance 
was the inactivity of intermediates between methionine and 
cephalosporin C, e.g., cystathion~ne and cysteine. Studies of 
an early blocked sulfur auxotroph (274-1), which grows on 
cysteine, cystathionine, .and methionine but not on sulfate, 
demonstrated the utility of such organic sulfur sources in anti-
biotic production. It was reasoned that if methionine were 
acting solely as a sulfur precursor for the antibiotic, the sul-
fur amino acids should stimulate cephalosporin C production in 
the order cysteine > cystathionine > methionine. The order 
actually observed (DREW and DEMAIN, 1975b) was the opposite of 
the above, i.e., methionine> cystathionine > cysteine. This 
observation suggested that cysteine and cystathionine must be 
first converted into methionine by transsulfuration before they 
can stimulate antibiotic formation, even though their activity 
as sulfur precursors should not involve methionine. To examine 
this point, various types of sulfur auxotrophs were utilized. 
For example, it was known that the early blocked auxotroph 274-1 
could produce cephalosporin C when growing on cysteine. The 
pathway from cysteine to cephalosporin C should not involve 
methionine as an intermediate. An experiment was done to 
determine whether genetically blocking transsulfuration from 
cysteine to methionine would affect cephalosporin C production 
(DREW and DEMAIN, 1975b). A second block was added to 274-1 to 
produce double mutant 11-8, which grew on methionine but not on 
cysteine. This methionine auxotroph w as grown with just enough 
methionine to allow normal growth in the presence of excess 
cysteine. Little or no antibiotic was produced unless excess 
methionine was added. Of crucial significance was the finding 
that excess norleucine could replace excess methionine--and 
norleucine contains no sulfur! It thus appears that methionine 
is a regulator of cephalosporin C production. However, we still 
do not know the mechanism. 
Other possible examples of induction include the stimula-
tion of (a) fosfomycin synthesis by the methyl group precursor 
methionine (ROGERS and BIRNBAUM, 1974), (b) virginiamycin syn-
thesis by a molecule excreted by the producer, S tr ept omy c es 
v i r giniae (YANAGIMOTO and TERUI, 1971b), and (c) rifamycin for-
mation in No c ar d i a medi terrane i by diethylbarbiturate (LANCINI 
and WHITE, 1973). 
ATP REGULATION IN SECONDARY METABOLISM 
Chlortetracycline formation is markedly reduced by inor-
ganic phosphate; in batch fermentations, the idiophase begins 
when phosphate in the medium is exhausted. Since chlortetra-
cycline biosynthesis involves no known phosphorylated inter-
mediates, the detrimental effect of phosphate probably does not 
involve feedback regulation of phosphates. There is a distinct 
possibility that the mechanism of phosphate inhibition of chlor-
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tetracycline biosynthesis involves regulation by ATP or energy 
charge. Janglova et al. (1969) examined the ATP content of _two 
strains of Streptomyce s aureofaciens, one a low producer (200 
µg/ml) and the other a high producer (2000 µg/ml) of chlortetra-
cycline. In both strains, ATP concentration increased during 
growth, th~n rapidly decreased and remained at a low level for 
the rest of the fermentation cycle. Throughout the experiment, 
the low producer was found to have two to four times as much 
ATP as the high producer. 
Like chlortetracycline, candicidin is best produced at a 
phosphate concentration that limits growth (LIU et al., 1975a). 
The addition of phosphate at any time inhibits candicidin pro-
duction and stimulates growth, glucose utilization, and oxygen 
uptake. In the normal fermentation, the internal concentration 
of ATP drops sharply at the end of DNA replication but before 
antibiotic synthesis (MARTIN and DEMAIN, unpublished). This 
phenomenon suggests that the addition of phosphate inhibits 
antibiotic formation by increasing intracellular ATP. Indeed, 
the addition of inorganic phosphate leads to an immediate three-
fold increase in the intracellular level of ATP (MARTIN and 
DEMAIN, unpublished). Phosphate-resistant mutants are now 
under study. 
Inorganic phosphate, which at high levels totally inhibits 
alkaloid formation, has been shown to repress the first enzyme 
unique to alkaloid biosynthesis (dimethylallyl tryptophan syn-
thetase) (KRUPINSKI et al., 1976) as well as chanoclavine-I-
cyclase in Clavic e ps SD58 (ERGE et al., 1973). The addition 
of tryptophan, thiotryptophan, or other analogues that reverse 
phosphate inhibition of alkaloid synthesis derepresses these 
enzymes (KRUPINSKI et al., 1976). The mechanism that links 
phosphate inhibition and tryptophan induction of alkaloid syn-
thesis is still unknown. 
THE TROPHOPHASE - IDIOPHASE RELATIONSHIP 
IN SECONDARY METABOLISM 
An interesting problem of secondary metabolism centers on 
the mechanism by which the formation of secondary products is 
usually retarded until the trophophase approaches completion. 
Secondary metabolites fail to appear during growth because the 
enzymes responsible for their formation are repressed during 
the trophophase (DEMAIN, 1974b). Unfortunately, we know very 
little about the repression-depression mechanisms involved, but 
they probably include some of the mechanisms mentioned above. 
For example, carbon catabolite repression of phenoxazinone syn-
thetase probably is important in the actinomycin fermentation. 
During our studies on the biosynthesis of gramicidin S (GS) 
(DEMAIN et al., 1975), we obtained data suggesting that, in 
certain fermentations, the growth rate regulates the formation 
of antibiotic synthetases. As with many secondary metabolites, 
GS is not produced until late in the cell cycle because the GS 
synthetases are not formed until the latter part of the log-
arithmic growth phase. After reaching the peak of their 
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specific activities, the enzymes rapidly disappear as the cells 
proceed into the stationary growth phase. We wondered whether 
the onset of synthetase formation was due to an exhaustion of 
a specific compound or to a decrease in growth rate. We turned 
to the chemostat to answer this question, since continuous cul-
ture allows for an examination of nutritional deficiency inde-
pendent of growth rate. The basic medium contained glycerol, 
ammonium, sulfate, and phosphate as single sources of C, N, s, 
and P. Successful production of GS synthetases I and II was 
achieved by limiting carbon, nitrogen, sulfur, or phosphorus. 
Synthetase production was low at high dilution rates (0.45 to 
0.50 hr- 1 ) and increased as the dilution rate was lowered. It 
thus appears that a high growth rate is incompatible with GS 
synthetase production. Although the mechanism is unknown, it 
is clear that such a relationship precludes synthetase formation 
during exponential growth in batch culture and allows synthetase 
formation as the cells leave the logarithmic growth phase. · 
As the dilution rate was further decreased in the chemo-
stat, enzyme specific activity reached a peak and then dropped. 
The peak occurred at different growth rates for each type of 
limitation, i.e., at 0.38 hr- 1 for nitrogen, 0.32 hr- 1 for car-
bon, 0.22 hr- 1 for sulfur, and 0.18 hr- 1 for phosphorus limita-
tion. The highest specific activity was obtained under a Fhes-
phorus or sulfur limitation. The reason for the decline in en-
zyme activity at very low dilution rates is not known but could 
be due to the activity of an "inactivase" formed at low growth 
rates, especially under carbon or nitrogen deficiency. 
GENETIC IMPROVEMENT OF IDIOLITE PRODUCTION 
Many of the metabolic controls described above can be by-
passed or exploited by environmental manipulation. Thus, tryp-
tophan can be added to an ergot alkaloid fermentation to induce 
the secondary process; phosphate is restricted in streptomycin 
fermentations to avoid feedback inhibition of phosphatases; 
and rapidly metabolized sugars, such as glucose, are either 
avoided or fed slowly to penicillin fermentations to prevent 
catabolite repression. However, since each of the regulatory 
mechanisms is genetically determined, mutation has had a major 
effect on the production of secondary metabolites (DEMAIN, 
1973). Strain improvement programs, which have utilized 
various mutagens, are chiefly responsible for the dramatic in-
creases in the production of antibiotics over the years. Pen-
icillin titers, for example, have increased from 5 mg/liter to 
20,000 to 30,000 mg/liter in 30 years of development. Most in-
dustrial mutation programs are conducted by randomly testing 
surviving clones in shaken flasks. In addition, colonies with 
genetically altered morphology or color are often selected for 
testing in liquid cultures. Unfortunately, we know little or 
nothing of the mechanisms responsible for superier preauction 
by such mutants. 
Some success has been experienced in applying concepts de-
rived from studies dealing with the effect of mutation on regu-
latory control of primary biosynthesis. For example, the re-
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moval of a primary biosynthetic enzyme activity by mutation 
and its suppression by a second mutation often yields feed-
back-resistant mutants. With regard to secondary metabolism, 
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it has been found that suppression of an ilv mutation in Strep -
tomyce s an t ibioticus , a met mutation in S t reptomyces viridi -
fa c iens, and a ay s mutation in Str eptomy c es lipmanii improved 
production of actinomycin (POLSINELLI et al., 1965), chlortetra-
cyli ne (DULANEY and DULANEY, 1967), and cephamycin C (GODFREY, 
1973), respectively. The development of mutants resistant to 
toxic analogues of precursors has also led to improved idio-
lite-producing mutants. For example, certain mutants of 
Pseudom onas aureofaaiens resistant to tryptophan analogues 
turned out to be improved pyrrolnitrin producers (ELANDER et 
al., 1971), and a trifluoroleucine-resistant mutant of S . 
Zipmanii produced three times more cephamycin C than its 
parent (GODFREY, 1973). S~nce secondary metabolites often in-
hibit the growth of the producing culture, the antibiotics them-
selves have been used to select for higher-producing mutants. 
Mutation has also been employed to eliminate undesirable 
or less active products when the microbial broth contains a 
mixture of such metabolites (DEMAIN, 1973). Another useful 
genetic application has been the production of new, active 
secondary metabolites either by simple blockage of the second-
ary pathway (McCORMICK et al., 1957) or by genetically elimina-
ting the ability to make one moiety of the product and feeding 
analogues of the missing moiety to the mutant ("mutational bio-
synthesis") (SHIER et al., 1969; NAGAOKA and DEMAIN, 1975). 
Such nonproducing mutants ("idiotrophs") have also been ex-
tremely useful in elucidating the pathways of secondary metab-
olism (DEMAIN, 1973). 
GENETICS OF SECONDARY METABOLISM 
Of g reat importance for the future development of second-
ary metabolite fermentations will be the mapping of production 
genes. Only recently have studies begun on the genetic maps 
of producing organisms such as actinomycetes. The model for 
such investigations is the genetic map of S t reptomyce s aoeli -
color , as developed by the techniques of HOPWOOD et al. (1973) 
and SERMONTI (1969). The map of s . coelico lo r is very similar 
to those of other S t reptomyae s species, such as S . bikiniensi s 
(COATS and ROESER, 1971), S . oZi v aceus (MASTELYUKH et al., 
1973), and S . glauescens (BAUMANN et al., 1974). More impor-
tant, genetic maps of commercial species, such as S . r imosus 
(oxytetracycline) (ALACEVIC et al., 1973) and Noca r dia mediter-
r anei (rifamycins) (SCHUPP et al., 1975), appear to be similar 
to that of S . a·oeli a oZor. Of recent interest is the finding 
that actinomycetes contain plasmids. In s . aoeZicolor, the 
plasmid is a sex factor (SCPl) that can be transferred to 
Streptomyaes Zividan s along with chromosomal genes (HOPWOOD, 
1974). Such plasmid transfer techniques should prove useful 
in amplifying production genes in industrial strains. KIRBY 
et al. (1975) have found at least four of the s. ao e l icolo r 
genes coding for enzymes of antibiotic (methylenomycin A) for-
mation to reside on the plasmid. 
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